Principal Financial Group Inc. purchased a new stake in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 223,910 shares of the medical equipment provider’s stock, valued at approximately $3,952,000. Principal Financial Group Inc. owned about 0.60% of Lantheus Holdings at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in LNTH. Bank of New York Mellon Corp lifted its holdings in Lantheus Holdings by 6.3% during the 1st quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock valued at $856,000 after purchasing an additional 4,084 shares during the last quarter. Parametric Portfolio Associates LLC lifted its holdings in Lantheus Holdings by 28.9% during the 1st quarter. Parametric Portfolio Associates LLC now owns 22,530 shares of the medical equipment provider’s stock valued at $282,000 after purchasing an additional 5,058 shares during the last quarter. Systematic Financial Management LP acquired a new stake in Lantheus Holdings during the 1st quarter valued at $1,314,000. California Public Employees Retirement System lifted its holdings in Lantheus Holdings by 29.2% during the 1st quarter. California Public Employees Retirement System now owns 77,800 shares of the medical equipment provider’s stock valued at $973,000 after purchasing an additional 17,600 shares during the last quarter. Finally, Koch Industries Inc. acquired a new stake in Lantheus Holdings during the 1st quarter valued at $153,000. 84.35% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/10/05/principal-financial-group-inc-takes-3-95-million-position-in-lantheus-holdings-inc-lnth.html.

In other Lantheus Holdings news, CEO Mary Anne Heino sold 10,000 shares of the company’s stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $18.05, for a total value of $180,500.00. Following the completion of the transaction, the chief executive officer now owns 592,468 shares in the company, valued at approximately $10,694,047.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Derace L. Schaffer sold 15,000 shares of the company’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $17.50, for a total value of $262,500.00. Following the completion of the transaction, the director now owns 48,730 shares of the company’s stock, valued at approximately $852,775. The disclosure for this sale can be found here. Insiders sold a total of 906,344 shares of company stock valued at $15,499,626 in the last 90 days. Corporate insiders own 2.30% of the company’s stock.

Shares of Lantheus Holdings, Inc. (LNTH) opened at 17.90 on Thursday. The stock’s 50 day moving average price is $17.43 and its 200-day moving average price is $17.43. Lantheus Holdings, Inc. has a 12-month low of $7.61 and a 12-month high of $18.25. The firm has a market cap of $668.57 million, a P/E ratio of 24.45 and a beta of 0.91.

Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings data on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.18. The firm had revenue of $88.83 million during the quarter, compared to the consensus estimate of $80.56 million. Lantheus Holdings had a negative return on equity of 37.47% and a net margin of 8.44%. The business’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.24 EPS. On average, analysts predict that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current fiscal year.

Several equities research analysts have issued reports on LNTH shares. Jefferies Group LLC reaffirmed a “buy” rating and set a $18.00 price target on shares of Lantheus Holdings in a report on Friday, June 30th. BidaskClub downgraded Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 17th. Zacks Investment Research downgraded Lantheus Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 5th. Credit Suisse Group raised their price target on Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, August 2nd. Finally, Cantor Fitzgerald started coverage on Lantheus Holdings in a report on Monday, July 17th. They set an “overweight” rating and a $22.00 price target for the company. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $18.60.

Lantheus Holdings Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).

Institutional Ownership by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Stock Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related stocks with our FREE daily email newsletter.